SB MEDICS LIMITED

Company Registration Number:
09297480 (England and Wales)

Unaudited abridged accounts for the year ended 30 November 2024

Period of accounts

Start date: 01 December 2023

End date: 30 November 2024

SB MEDICS LIMITED

Contents of the Financial Statements

for the Period Ended 30 November 2024

Balance sheet
Notes

SB MEDICS LIMITED

Balance sheet

As at 30 November 2024


Notes

2024

2023


£

£
Fixed assets
Tangible assets: 3 261,946 185,152
Total fixed assets: 261,946 185,152
Current assets
Debtors:   90,097 74,367
Cash at bank and in hand: 30,920 153,739
Total current assets: 121,017 228,106
Creditors: amounts falling due within one year:   (49,889) (90,269)
Net current assets (liabilities): 71,128 137,837
Total assets less current liabilities: 333,074 322,989
Total net assets (liabilities): 333,074 322,989
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 333,073 322,988
Shareholders funds: 333,074 322,989

The notes form part of these financial statements

SB MEDICS LIMITED

Balance sheet statements

For the year ending 30 November 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 21 August 2025
and signed on behalf of the board by:

Name: B Sibanda
Status: Director

The notes form part of these financial statements

SB MEDICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

SB MEDICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

2. Employees

2024 2023
Average number of employees during the period 10 5

SB MEDICS LIMITED

Notes to the Financial Statements

for the Period Ended 30 November 2024

3. Tangible Assets

Total
Cost £
At 01 December 2023 194,818
Additions 79,781
At 30 November 2024 274,599
Depreciation
At 01 December 2023 9,666
Charge for year 2,987
At 30 November 2024 12,653
Net book value
At 30 November 2024 261,946
At 30 November 2023 185,152